MLC1 | Megalencephalic leukoencephalopathy with subcortical cysts 1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
MPDU1 | Mannose-P-dolichol utilization defect 1 | Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
MS4A1 | Membrane-spanning 4-domains, subfamily A, member 1 | CD markers Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
MYADM | Myeloid-associated differentiation marker | Predicted membrane proteins Transporters
| | | | | Expressed in all |
NOX4 | NADPH oxidase 4 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
NPC1 | Niemann-Pick disease, type C1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
NPSR1 | Neuropeptide S receptor 1 | Disease related genes G-protein coupled receptors Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
OPRM1 | Opioid receptor, mu 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
P2RY6 | Pyrimidinergic receptor P2Y, G-protein coupled, 6 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
PARL | Presenilin associated, rhomboid-like | Enzymes Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
PCNXL2 | Pecanex-like 2 (Drosophila) | Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
PGAP2 | Post-GPI attachment to proteins 2 | Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
PGAP3 | Post-GPI attachment to proteins 3 | Disease related genes Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
PHTF2 | Putative homeodomain transcription factor 2 | Predicted membrane proteins Transcription factors
| | | | | Expressed in all |
PIGF | Phosphatidylinositol glycan anchor biosynthesis, class F | Predicted membrane proteins
| | | | | Expressed in all |
PIGO | Phosphatidylinositol glycan anchor biosynthesis, class O | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
PIGU | Phosphatidylinositol glycan anchor biosynthesis, class U | Predicted membrane proteins
| | | | | Expressed in all |
POMT1 | Protein-O-mannosyltransferase 1 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
PPAPDC1A | Phosphatidic acid phosphatase type 2 domain containing 1A | Enzymes Predicted membrane proteins
| | | | | Group enriched |
PPAPDC1B | Phosphatidic acid phosphatase type 2 domain containing 1B | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
PQLC1 | PQ loop repeat containing 1 | Predicted membrane proteins
| | | | | Expressed in all |
PQLC2 | PQ loop repeat containing 2 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
PROM1 | Prominin 1 | CD markers Disease related genes Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
PROM2 | Prominin 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
PTCHD3 | Patched domain containing 3 | Predicted membrane proteins
| | | | | Tissue enriched |
PTDSS1 | Phosphatidylserine synthase 1 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
PTPLAD2 | Protein tyrosine phosphatase-like A domain containing 2 | Enzymes Predicted membrane proteins
| | | | | Mixed |
QRFPR | Pyroglutamylated RFamide peptide receptor | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
RFT1 | RFT1 homolog (S. cerevisiae) | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
RHBDD2 | Rhomboid domain containing 2 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
RHBDL1 | Rhomboid, veinlet-like 1 (Drosophila) | Enzymes Predicted membrane proteins
| | | | | Mixed |
RHCG | Rh family, C glycoprotein | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
RNF26 | Ring finger protein 26 | Predicted membrane proteins
| | | | | Expressed in all |
SCD | Stearoyl-CoA desaturase (delta-9-desaturase) | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
SCD5 | Stearoyl-CoA desaturase 5 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
SCN7A | Sodium channel, voltage-gated, type VII, alpha subunit | Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
SFXN1 | Sideroflexin 1 | Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
SFXN2 | Sideroflexin 2 | Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
SFXN4 | Sideroflexin 4 | Disease related genes Mitochondrial proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SFXN5 | Sideroflexin 5 | Mitochondrial proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
SLC12A5 | Solute carrier family 12 (potassium/chloride transporter), member 5 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC13A2 | Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC13A3 | Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC14A1 | Solute carrier family 14 (urea transporter), member 1 (Kidd blood group) | Blood group antigen proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC16A10 | Solute carrier family 16 (aromatic amino acid transporter), member 10 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC16A3 | Solute carrier family 16 (monocarboxylate transporter), member 3 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC16A4 | Solute carrier family 16, member 4 | Predicted membrane proteins
| | | | | Tissue enhanced |
SLC16A5 | Solute carrier family 16 (monocarboxylate transporter), member 5 | Predicted membrane proteins Transporters
| | | | | Mixed |
SLC17A4 | Solute carrier family 17, member 4 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC19A1 | Solute carrier family 19 (folate transporter), member 1 | Cancer-related genes Predicted membrane proteins Transporters
| | | | | Expressed in all |